114 related articles for article (PubMed ID: 7537561)
21. Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16.
Storey A; Oates D; Banks L; Crawford L; Crook T
Nucleic Acids Res; 1991 Aug; 19(15):4109-14. PubMed ID: 1651476
[TBL] [Abstract][Full Text] [Related]
22. Phosphorothioate oligodeoxynucleotides inhibit basic fibroblast growth factor-induced angiogenesis in vitro and in vivo.
Kitajima I; Unoki K; Maruyama I
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):233-9. PubMed ID: 10355829
[TBL] [Abstract][Full Text] [Related]
23. Binding of phosphorothioate oligodeoxynucleotides to basic fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent.
Benimetskaya L; Tonkinson JL; Koziolkiewicz M; Karwowski B; Guga P; Zeltser R; Stec W; Stein CA
Nucleic Acids Res; 1995 Nov; 23(21):4239-45. PubMed ID: 7501441
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of hepatitis B viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
Yao ZQ; Zhou YX; Wang AL; Bai XF; Yang WS
J Viral Hepat; 1995; 2(2):85-9. PubMed ID: 7493302
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in rats.
Stepkowski SM; Qu X; Wang ME; Tian L; Chen W; Wancewicz EV; Johnston JF; Bennett CF; Monia BP
Transplantation; 2000 Aug; 70(4):656-61. PubMed ID: 10972225
[TBL] [Abstract][Full Text] [Related]
26. Effects of synthetic oligonucleotides on human complement and coagulation.
Shaw DR; Rustagi PK; Kandimalla ER; Manning AN; Jiang Z; Agrawal S
Biochem Pharmacol; 1997 Apr; 53(8):1123-32. PubMed ID: 9175717
[TBL] [Abstract][Full Text] [Related]
27. Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells.
De Luca A; Selvam MP; Sandomenico C; Pepe S; Bianco AR; Ciardiello F; Salomon DS; Normanno N
Int J Cancer; 1997 Oct; 73(2):277-82. PubMed ID: 9335455
[TBL] [Abstract][Full Text] [Related]
28. Pseudo-cyclic oligonucleotides: in vitro and in vivo properties.
Jiang Z; Kandimalla ER; Zhao Q; Shen LX; DeLuca A; Normano N; Ruskowski M; Agrawal S
Bioorg Med Chem; 1999 Dec; 7(12):2727-35. PubMed ID: 10658577
[TBL] [Abstract][Full Text] [Related]
29. Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera.
Akhtar S; Kole R; Juliano RL
Life Sci; 1991; 49(24):1793-801. PubMed ID: 1943483
[TBL] [Abstract][Full Text] [Related]
30. Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor.
Rubenstein M; Glick R; Lichtor T; Mirochnik Y; Chou P; Guinan P
Med Oncol; 2001; 18(2):121-30. PubMed ID: 11778757
[TBL] [Abstract][Full Text] [Related]
31. The binding of anti-DNA antibodies to phosphorothioate oligonucleotides in a solid phase immunoassay.
Pisetsky DS; Reich CF
Mol Immunol; 1998 Dec; 35(18):1161-70. PubMed ID: 10199390
[TBL] [Abstract][Full Text] [Related]
32. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
[TBL] [Abstract][Full Text] [Related]
33. Specific inhibition of interleukin-10 production in murine macrophage-like cells by phosphorothioate antisense oligonucleotides.
Arima H; Takahashi M; Aramaki Y; Sakamoto T; Tsuchiya S
Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):319-27. PubMed ID: 9743469
[TBL] [Abstract][Full Text] [Related]
34. Interactions between single-stranded DNA binding protein and oligonucleotide analogs with different backbone chemistries.
Cheng X; DeLong RK; Wickstrom E; Kligshteyn M; Demirdji SH; Caruthers MH; Juliano RL
J Mol Recognit; 1997; 10(2):101-7. PubMed ID: 9376128
[TBL] [Abstract][Full Text] [Related]
35. Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies.
Lorenz P; Baker BF; Bennett CF; Spector DL
Mol Biol Cell; 1998 May; 9(5):1007-23. PubMed ID: 9571236
[TBL] [Abstract][Full Text] [Related]
36. Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicity.
Chen W; Langer RM; Janczewska S; Furian L; Geary R; Qu X; Wang M; Verani R; Condon T; Stecker K; Bennett CF; Stepkowski SM
Transplantation; 2005 Feb; 79(4):401-8. PubMed ID: 15729165
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of mouse hepatitis virus multiplication by phosphorothioate analogues of oligodeoxynucleotides complementary to the leader RNA.
Hayashi M; Maeda A; Watanabe T; Hanaki K; Arai S; Nozaki S
J Vet Med Sci; 1995 Dec; 57(6):1081-3. PubMed ID: 8720052
[TBL] [Abstract][Full Text] [Related]
38. Novel enzymatic and immunological responses to oligonucleotides.
Agrawal S; Rustagi PK; Shaw DR
Toxicol Lett; 1995 Dec; 82-83():431-4. PubMed ID: 8597089
[TBL] [Abstract][Full Text] [Related]
39. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
Reed JC; Stein C; Subasinghe C; Haldar S; Croce CM; Yum S; Cohen J
Cancer Res; 1990 Oct; 50(20):6565-70. PubMed ID: 2208117
[TBL] [Abstract][Full Text] [Related]
40. Specific inhibition of nitric oxide production in macrophages by phosphorothioate antisense oligonucleotides.
Arima H; Sakamoto T; Aramaki Y; Ishidate K; Tsuchiya S
J Pharm Sci; 1997 Oct; 86(10):1079-84. PubMed ID: 9344161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
